Abstract
Low urinary citrate is a risk factor in calcium renal stone disease.
The aim of this work was to identify the factors responsible for the low excretion of citrate frequently observed in patients with spinal cord lesions.
Thirty male patients with spinal cord lesions were studied by blood and urine biochemistry.
The most important single factor related to urinary citrate was urinary potassium. The presence or absence of urinary stone disease and variations in urinary volume also contributed significantly to variations in citrate excretion.
Determination of plasma and urinary citrate, urinary sodium and bacteriological culture of urine permitted complete discrimination of the 7 stone formers from the other patients.
Similar content being viewed by others
Article PDF
References
Burr R G 1981 Calculosis in paraplegia. International Rehabilitation Medicine 3: 162–167.
Burr R G, Nuseibeh I, Abiaka C D 1985 Biochemical studies in paraplegic renal stone formers—2. Urinary excretion of citrate, inorganic pyrophosphate, silicate and urate. British Journal of Urology 57: 275–278.
Chaney A L C, Marbach E P M 1962 Modified reagents for determination of urea and ammonia. Clinical Chemistry 8: 130–132.
Daley J A D, Ertingshausen G 1972 Direct method for determining phosphate in serum with the ‘Centrifichem’. Clinical Chemistry 18: 263–265.
Fleisch H F 1978 Inhibitors and promotors of stone formation. Kidney International 13: 361–371.
Fourman P, Robinson J R 1953 Diminished urinary excretion of citrate during potassium deficiency in man. Lancet 2: 656–657.
Gindler E M G, King J D K 1972 Rapid colorimetric determination of calcium in biologic fluids with methyl thymol blue. American Journal of Clinical Pathology 58: 376–382.
Jaeger P h, Portmann L, Jaquet A F, Burckhardt, P 1988 Study of the mechanisms of hypocitraturia in idiopathic stone formers. In: Martelli A, Buli P, Marchesini B (eds) Inhibitors of Crystallization in Renal Lithiasis and their Clinical Application. ICEP, Roma, pp 183–186.
Marangella M, Bianco O, Grande M L et al. 1987 Patterns of citrate excretion in healthy subjects and patients with idiopathic stone disease. Pathogenesis of Nephrolithiasis, Contributions to Nephrology 58: 34–38.
Marangella M, Linari F 1988 Clinical and biochemical aspects of citrate excretion in idiopathic calcium nephrolithiasis. In: Martelli A, Buli P, Marchesini B (eds) Inhibitors of Crystallization in Renal Lithiasis and their Clinical Application. ICEP, Roma, pp 145–149.
Nicar M J, Skurla C, Sakhaee K, Pak C Y C 1983 Low urinary citrate excretion in nephrolithiasis. Urology 21: 8–14.
Rudman D, Dedonis J L, Fountain M T et al. 1980 Hypocitraturia in patients with gastrointestinal malabsorption. New England Journal of Medicine 303: 657–661.
Schwille P O, Scholz D, Schwille K et al 1982 Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an out-patient stone clinic. Nephron 31: 194–202.
Simpson D P S 1983 Citrate excretion: a window on renal metabolism. American Journal of Physiology 244: F223–234.
Sinha R S, Trew J A T 1971 Effect of calcium and phosphate on an automated fluorimetric determination of magnesium in biological fluids. Clinical Biochemistry 4: 128–133.
Sutor D J S, Percival J M P 1978 The estimation of D-isocitric acid in urine using isocitrate dehydrogenase. Clinica Chimica Acta 86: 223–225.
Sutor D J S, Wilkie L I W 1978 The estimation of pyrophosphate in urine with uridine-5′-diphosphoglucose pyrophosphorylase. Clinica Chimica Acta 86: 329–332.
Welshman S G W, McCambridge H M 1973 The estimation of citrate in serum and urine using a citrate lyase technique. Clinica Chimica Acta 46: 243–246.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burr, R., Nuseibeh, I. Citrate excretion in spinal cord patients. Spinal Cord 28, 496–504 (1990). https://doi.org/10.1038/sc.1990.66
Issue Date:
DOI: https://doi.org/10.1038/sc.1990.66